Literature DB >> 19147535

Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.

Olivier Ayrault1, Frederique Zindy, Jerold Rehg, Charles J Sherr, Martine F Roussel.   

Abstract

Two cyclin-dependent kinase inhibitors, p18(Ink4c) and p27(Kip1), are required for proper cerebellar development. Loss of either of these proteins conferred a proliferative advantage to granule neuron progenitors, although inactivation of Kip1 exerted a greater effect. Mice heterozygous for Patched-1 (Ptc1+/-) that are either heterozygous or nullizygous for Kip1 developed medulloblastoma rapidly and with high penetrance. All tumors from Ptc1+/-;Kip1+/- or Ptc1+/-;Kip1-/- mice failed to express the wild-type Ptc1 allele, consistent with its role as a canonical "two-hit" tumor suppressor. In contrast, expression of the wild-type p27(Kip1) protein was invariably maintained in medulloblastomas arising in Ptc1+/-;Kip1+/- mice, indicating that Kip1 is haploinsufficient for tumor suppression. Although medulloblastomas occurring in Ptc1+/- mice were histopathologically heterogeneous and contained intermixed regions of both rapidly proliferating and nondividing more differentiated cells, tumors that also lacked Kip1 were uniformly less differentiated, more highly proliferative, and invasive. Molecular analysis showed that the latter medulloblastomas exhibited constitutive activation of the Sonic hedgehog signaling pathway without loss of functional p53. Apart from gains or losses of single chromosomes, with gain of chromosome 6 being the most frequent, no other chromosomal anomalies were identified by spectral karyotyping, and half of the medulloblastomas so examined retained a normal karyotype. In this respect, this mouse medulloblastoma model recapitulates the vast majority of human medulloblastomas that do not sustain TP53 mutations and are not aneuploid.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147535      PMCID: PMC2637533          DOI: 10.1158/1541-7786.MCR-08-0369

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  39 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Control of proliferation and differentiation of neural precursor cells: focusing on the developing cerebellum.

Authors:  Yasuki Ishizaki
Journal:  J Pharmacol Sci       Date:  2006-07-06       Impact factor: 3.337

Review 3.  Hedgehog and patched in neural development and disease.

Authors:  L V Goodrich; M P Scott
Journal:  Neuron       Date:  1998-12       Impact factor: 17.173

Review 4.  Ptc1 heterozygous knockout mice as a model of multi-organ tumorigenesis.

Authors:  Simonetta Pazzaglia
Journal:  Cancer Lett       Date:  2005-05-31       Impact factor: 8.679

5.  Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma.

Authors:  Trudy G Oliver; Tracy Ann Read; Jessica D Kessler; Anriada Mehmeti; Jonathan F Wells; Trang T T Huynh; Simon M Lin; Robert J Wechsler-Reya
Journal:  Development       Date:  2005-04-20       Impact factor: 6.868

6.  XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice.

Authors:  Catherine T Yan; Dhruv Kaushal; Michael Murphy; Yu Zhang; Abhishek Datta; Changzhong Chen; Brianna Monroe; Gustavo Mostoslavsky; Kristen Coakley; Yijie Gao; Kevin D Mills; Alex P Fazeli; Suprawee Tepsuporn; Giles Hall; Richard Mulligan; Edward Fox; Roderick Bronson; Umberto De Girolami; Charles Lee; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-02       Impact factor: 11.205

7.  The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.

Authors:  Tamar Uziel; Frederique Zindy; Suqing Xie; Youngsoo Lee; Antoine Forget; Susan Magdaleno; Jerold E Rehg; Christopher Calabrese; David Solecki; Charles G Eberhart; Sarah E Sherr; Sarah Plimmer; Steven C Clifford; Mary E Hatten; Peter J McKinnon; Richard J Gilbertson; Tom Curran; Charles J Sherr; Martine F Roussel
Journal:  Genes Dev       Date:  2005-10-31       Impact factor: 11.361

8.  N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.

Authors:  Frederique Zindy; Paul S Knoepfler; Suqing Xie; Charles J Sherr; Robert N Eisenman; Martine F Roussel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

Review 9.  Medulloblastoma: developmental mechanisms out of control.

Authors:  Silvia Marino
Journal:  Trends Mol Med       Date:  2005-01       Impact factor: 11.951

10.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression.

Authors:  M L Fero; E Randel; K E Gurley; J M Roberts; C J Kemp
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

View more
  34 in total

Review 1.  Genetic and molecular alterations across medulloblastoma subgroups.

Authors:  Patryk Skowron; Vijay Ramaswamy; Michael D Taylor
Journal:  J Mol Med (Berl)       Date:  2015-09-09       Impact factor: 4.599

2.  Embryonic lethal abnormal vision-like HuR-dependent mRNA stability regulates post-transcriptional expression of cyclin-dependent kinase inhibitor p27Kip1.

Authors:  Gudrun Ziegeler; Jie Ming; Jana C Koseki; Sema Sevinc; Ting Chen; Suleyman Ergun; Xuebin Qin; Bertal H Aktas
Journal:  J Biol Chem       Date:  2010-03-23       Impact factor: 5.157

3.  The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells.

Authors:  Daniel P Dever; Lisa A Opanashuk
Journal:  Mol Pharmacol       Date:  2012-02-06       Impact factor: 4.436

4.  VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells.

Authors:  Lymor Ringer; Paul Sirajuddin; Mary Heckler; Anup Ghosh; Frank Suprynowicz; Venkata M Yenugonda; Milton L Brown; Jeffrey A Toretsky; Aykut Uren; YiChien Lee; Tobey J MacDonald; Olga Rodriguez; Robert I Glazer; Richard Schlegel; Chris Albanese
Journal:  Cancer Biol Ther       Date:  2011-11-01       Impact factor: 4.742

5.  p27(Kip1), a double-edged sword in Shh-mediated medulloblastoma: Tumor accelerator and suppressor.

Authors:  Bobby Bhatia; Arfa Malik; Africa Fernandez-L; Anna Marie Kenney
Journal:  Cell Cycle       Date:  2010-11-27       Impact factor: 4.534

6.  Regulation of USP37 Expression by REST-Associated G9a-Dependent Histone Methylation.

Authors:  Tara H W Dobson; Rashieda J Hatcher; Jyothishmathi Swaminathan; Chandra M Das; Shavali Shaik; Rong-Hua Tao; Ciro Milite; Sabrina Castellano; Pete H Taylor; Gianluca Sbardella; Vidya Gopalakrishnan
Journal:  Mol Cancer Res       Date:  2017-05-08       Impact factor: 5.852

7.  Huwe1 ubiquitin ligase is essential to synchronize neuronal and glial differentiation in the developing cerebellum.

Authors:  Domenico D'Arca; Xudong Zhao; Wenming Xu; Nadya C Ramirez-Martinez; Antonio Iavarone; Anna Lasorella
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

Review 8.  Using Pharmacology to Squeeze the Life Out of Childhood Leukemia, and Potential Strategies to Achieve Breakthroughs in Medulloblastoma Treatment.

Authors:  Juwina Wijaya; Tomoka Gose; John D Schuetz
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

9.  Epigenetic states of cells of origin and tumor evolution drive tumor-initiating cell phenotype and tumor heterogeneity.

Authors:  Kin-Hoe Chow; Dong-Mi Shin; Molly H Jenkins; Emily E Miller; David J Shih; Seungbum Choi; Benjamin E Low; Vivek Philip; Brad Rybinski; Roderick T Bronson; Michael D Taylor; Kyuson Yun
Journal:  Cancer Res       Date:  2014-08-18       Impact factor: 12.701

10.  Mosaic Analysis with Double Markers reveals IGF1R function in granule cell progenitors during cerebellar development.

Authors:  Tiffany T Terry; Tao Cheng; Moe Mahjoub; Hui Zong
Journal:  Dev Biol       Date:  2020-07-19       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.